c16

PAF (C16) 是有效的 MAPK 和 MEK/ERK 激活剂，可诱导血管通透性增加。PAF (C16) (PAF (C16)) 是血小板活化因子，是一种磷脂衍生介质，也是 PAF G 蛋白偶联受体 (PAFR) 的配体。PAF (C16) 在体外实验中显示出抗凋亡和抗炎活性，通过与其受体 （PAF-R） 相互作用以执行细胞信号传导来抑制 caspase 依赖性凋亡。

C16 Ceramide (d16:1, C16:0) 是一种具有生物活性的鞘脂，能够在棕榈酰磷脂 (POPC) 双层中诱导富含棕榈酰鞘磷脂结构域的有序相和凝胶相的形成及其热稳定性。此化合物存在于人红细胞鞘磷脂中。

C16 Galactosylceramide 是一种鞘脂类化合物，参与脂质代谢和免疫调节等细胞内的生理过程，亦可用于糖尿病研究。

C16 Sphingomyelin (d18:1/16:0) (N-Palmitoyl-D-sphingomyelin) 是磷脂双层膜的磷脂类化合物，可用于研究生物膜的活性。

13C C16 Sphingomyelin is an isotopically enriched form of C16 sphingomyelin with carbon-13 occurring on the fatty acid portion. It is intended for use as an internal standard for the quantification of C16 sphingomyelin by GC- or LC-MS. C16 Sphingomyelin is a form of sphingomyelin containing palmitate (16:0) at the variable acylation position. It is the most common form of sphingomyelin found in eggs and is less abundant in the brain and in milk. C16 Sphingomyelin interacts with cholesterol in ordered lipid domains (lipid rafts). Sphingomyelinases remove phosphorylcholine from C16 sphingomyelin to produce C16 ceramide. While ceramides commonly induce apoptosis, ceramides with different fatty acid chain lengths might direct distinct functions and, in some cases, reduce apoptosis.

C16 globotriaosylceramide is an endogenous sphingolipid found in mammalian cell membranes that is synthesized from C16 lactosylceramide . C16 globotriaosylceramide acts as a receptor for Shiga toxin in B cell-derived Raji cells and THP-1 monocytes. It accumulates in endothelial cells, pericytes, vascular smooth muscle cells, renal epithelial cells, dorsal ganglia neuronal cells, and myocardial cells in patients with Fabry disease. C16 globotriaosylceramide is also upregulated in plasma of patients with ovarian carcinoma compared to those with benign ovarian tumors or uterine fibroids.

C16 Galactosylceramide is a glycosphingolipid that contains a galactose moiety attached to a ceramide acylated with palmitic acid .

C16 Phytoceramide (t18:0/16:0) is a phytoceramide, which is a family of sphingolipids found in the intestine, kidney, and extracellular spaces of the stratum corneum of the mammalian epidermis. C16 Phytoceramide (t18:0/16:0) is composed of a phytosphingosine backbone amine-linked to a C16 fatty acid chain. The levels of C16 phytoceramide (t18:0/16:0) increase following heat stress in S. cerevisiae. It has been used with other ceramides to create stratum corneum substitutes to study percutaneous penetration and psoriasis in vitro.

GLP-1R modulator C16 是一种变构调节剂，显著增加了 GLP-4 的结合亲和力。

C16 PEG-Ceramide为一种聚乙二醇化神经酰胺，具备脂质载体传递功能，并能诱导自噬(autophagy)，在癌症研究中有应用。

C16 1-Deoxyceramide (m18:1/16:0) 是一种脂质分子，可用于生命科学相关研究，其 CAS 号为 1246298-56-5。

C16((±)-2'-hydroxy) dihydro Ceramide (d18:0/16:0) 是一种脂质分子，可用于生命科学相关研究，其 CAS 号为 190249-36-6。

C16 Ceramide-1-phosphate (d18:1/16:0) ammonium salt (C16 C1P ammonium salt) 是一种酯类产品，可用于合成纳米生物制。

C16 (2'(S)-hydroxy) Ceramide (d18:1/16:0) 是一种脂质分子，可用于生命科学相关研究，其 CAS 号为 890041-50-6。

C16 PEG750 Ceramide (C16 PEG Ceramide (MW 750)) 是一种 PEG 脂质，用于制备脂质体，适用于药物递送研究。

C16 Ceramide-d7 是 C16 Ceramide 的氘代化合物。

Methylcarbamyl PAF C-16(Carbamyl-PAF) 是一种血小板活化因子类似物，具有 PAF 激动特性，可激活激活妊娠组织的炎症，促进早产。

Boc-C16-COOH 可以作为 ADC linker 或 PROTAC linker，用于合成抗体偶联药物或合成 PROTAC。

PKR-IN-C16 是一种特异性蛋白激酶抑制剂。它能够抑制 PKR 的自磷酸化，解除 PKR 在原代神经元细胞培养中诱导的翻译阻断。

Amino-PEG6-amido-C16-Boc is a PEG-based PROTAC linker employed for the synthesis of PROTACs[1].

Amino-PEG6-amido-C16-COOH, a PEG-based PROTAC linker, facilitates the synthesis of PROTACs[1].

Amino-PEG9-amido-C16-Boc is a polyethylene glycol (PEG)-based linker utilized for the synthesis of proteolysis-targeting chimeras (PROTACs)[1].

Azide-PEG6-amido-C16-Boc is an alkyl/ether-based PROTAC linker utilized in PROTAC synthesis[1].

Azide-PEG9-amido-C16-Boc is an alkyl/ether-based PROTAC linker with utility in PROTAC synthesis [1].